A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 Monotherapy and in Combination with Abiraterone in Patients with Metastatic Prostate Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date6/1/23 → 6/1/26

Funding

  • Pharmaceutical Research Associates, Inc. (Prot #ARV-766-mCRPC-101 // Prot #ARV-766-mCRPC-101)
  • Arvinas Androgen Receptor, Inc. (Prot #ARV-766-mCRPC-101 // Prot #ARV-766-mCRPC-101)